2 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
Follow Genetic Disorder: new trials by email Literature Review of Genetic Disorder trials Research Report on Genetic Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetics of Thymoglobulin in Paediatric Haematopoietic Stem-cell Transplants Thymoglobulin (rATG) - Malignancy, Metabolic Disease | Phase 2 | Terminated | The Hospital for Sick Children | 30 | 2009-11-01 | 2019-11-04 |
| Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, Tacrolimus, and Sirolimus in Treating Patients With Primary Immunodeficiency Disorders or Noncancerous Inherited Disorders Allogeneic Bone Marrow Transplantation, Cyclophosphamide, Fludarabine Phosphate - Immunodeficiency Syndrome, Severe Aplastic Anemia | Phase 2 | Terminated | Fred Hutchinson Cancer Center | 14 | 2006-05-24 | 2021-01-26 |
Genetic Diseases, Inborn (2) · Anemia, Aplastic (1) · Immunologic Deficiency Syndromes (1) · Metabolic Diseases (1) · Neoplasms (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Anemia (1) · Bone Marrow Diseases (1) · Bone Marrow Failure Disorders (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Nutritional and Metabolic Diseases (1)
Antilymphocyte Serum (1) · Cyclophosphamide (1) · Mycophenolic Acid (1) · Sirolimus (1) · Tacrolimus (1) · Whole-Body Irradiation (1) · fludarabine phosphate (1) · thymoglobulin (1)
Fred Hutchinson Cancer Center (1) · The Hospital for Sick Children (1)
Canada (1) · United States (1)
Kanwaldeep Mallhi (1) · Tal Schechter-Finkelstein, MD (1)
P01HL122173 (1), P30CA015704 (1)